Annual report pursuant to Section 13 and 15(d)

Share-based Compensation

v3.19.3.a.u2
Share-based Compensation
12 Months Ended
Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-based Compensation

Note 15 — Share-based Compensation

At December 31, 2019, we had two incentive plans; the 2007 Equity Compensation Plan (the “2007 Plan”) and the 2013 Equity Compensation Plan (the “2013 Plan” and with 2007 Plan, the “Plans”) which replaced the 2007 Plan.

The Company provides awards of options, stock appreciation rights, restricted stock awards, restricted stock unit awards, shares granted as a bonus or in lieu of another award, dividend equivalent, other stock-based award or performance award, together with any other right or interest to a participant. Plan participants include executives and other employees, officers, directors, consultants and other persons who provide services to the Company or its related entities. Although no future stock options may be granted under the earlier plans, certain employees, directors and officers of Hanmi Financial and its subsidiaries still hold options to purchase Hanmi Financial common stock under the 2007 Plan. Under the 2013 Plan, we may grant equity incentive awards for up to 1,500,000 shares of common stock. As of December 31, 2019, 348,922 shares were still available for issuance under the 2013 Plan.

The table below provides the share-based compensation expense and related tax benefits for the periods indicated:

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Share-based compensation expense

 

$

3,125

 

 

$

3,515

 

 

$

2,893

 

Related tax benefits

 

$

941

 

 

$

984

 

 

$

1,179

 

 

As of December 31, 2019, unrecognized share-based compensation expense was $4.5 million with an average expected recognition period of 2.0 years.

 

 

2013 and 2007 Equity Compensation Plans

Stock Options

All stock options granted under the Plans have an exercise price equal to the fair market value of the underlying common stock on the date of grant. Stock options granted generally vest based on three to five years of continuous service and expire 10 years from the date of grant. New shares of common stock are issued or treasury shares are utilized upon the exercise of stock options. There were no options granted during the three years ended December 31, 2019.

The following information under the Plans is presented for the periods indicated:

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Fair value of options vested

 

$

 

 

$

184

 

 

$

820

 

Total intrinsic value of options exercised (1)

 

$

842

 

 

$

 

 

$

432

 

Cash received from options exercised

 

$

2,979

 

 

$

 

 

$

288

 

 

(1)

Intrinsic value represents the difference between the closing stock price on the exercise date and the exercise price, multiplied by the number of options.

The following is a summary of stock option transactions under the Plans for the periods indicated:

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price Per

Share

 

Options outstanding at beginning of period

 

 

338,338

 

 

$

17.52

 

 

 

364,088

 

 

$

17.86

 

 

 

387,901

 

 

$

17.49

 

Options granted

 

 

 

 

$

 

 

 

 

 

$

 

 

 

 

 

$

 

Options exercised

 

 

(181,900

)

 

$

16.38

 

 

 

(25,750

)

 

$

22.06

 

 

 

(23,813

)

 

$

12.21

 

Options forfeited

 

 

 

 

$

 

 

 

 

 

$

 

 

 

 

 

$

 

Options expired

 

 

 

 

$

 

 

 

 

 

$

 

 

 

 

 

$

 

Options outstanding at end of period

 

 

156,438

 

 

$

18.84

 

 

 

338,338

 

 

$

17.52

 

 

 

364,088

 

 

$

17.86

 

Options exercisable at end of period

 

 

156,438

 

 

$

18.84

 

 

 

338,338

 

 

$

17.52

 

 

 

354,753

 

 

$

17.71

 

 

As of December 31, 2019 there was no unrecognized compensation cost related to nonvested stock options granted under the plan.

 

The following is a summary of transactions for non-vested stock options under the Plans for the periods indicated:

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price Per

Share

 

Non-vested options outstanding at beginning of period

 

 

 

 

$

 

 

 

9,335

 

 

$

23.47

 

 

 

46,340

 

 

$

22.42

 

Options granted

 

 

 

 

$

 

 

 

 

 

$

 

 

 

 

 

$

 

Options vested

 

 

 

 

$

 

 

 

(9,335

)

 

$

23.47

 

 

 

(37,005

)

 

$

22.16

 

Options forfeited

 

 

 

 

$

 

 

 

 

 

$

 

 

 

 

 

$

 

Non-vested options outstanding at end of period

 

 

 

 

$

 

 

 

 

 

$

 

 

 

9,335

 

 

$

23.47

 

 

As of December 31, 2019, stock options outstanding under the Plans were as follows:

 

 

 

Options Outstanding

 

Options Exercisable

 

 

Number of

Shares

 

 

Intrinsic

Value

(1)

 

 

Weighted-

Average

Average

Exercise

Price Per

Share

 

 

Weighted-

Average

Remaining

Contractual

Life

 

Number of

Shares

 

 

Intrinsic

Value

(1)

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Weighted-

Average

Remaining

Contractual

Life

$10.80 to $14.99

 

 

10,438

 

 

$

78

 

 

$

12.54

 

 

2.9 years

 

 

10,438

 

 

$

78

 

 

$

12.54

 

 

2.9 years

$15.00 to $19.99

 

 

85,000

 

 

 

270

 

 

 

16.82

 

 

3.8 years

 

 

85,000

 

 

 

270

 

 

 

16.82

 

 

3.8 years

$20.00 to $24.83

 

 

61,000

 

 

 

 

 

 

22.73

 

 

4.8 years

 

 

61,000

 

 

 

 

 

 

22.73

 

 

4.8 years

 

 

 

156,438

 

 

$

348

 

 

$

18.84

 

 

 

 

 

156,438

 

 

$

924

 

 

$

18.84

 

 

 

 

(1)

Intrinsic value represents the difference between the closing stock price on the last trading day of the period, which was $20.00 as of December 31, 2019, and the exercise price, multiplied by the number of options. This value is presented in thousands.

Restricted Stock Awards

Restricted stock awards under the Plans become fully vested after a certain number of years or after certain performance criteria are met. Hanmi Financial becomes entitled to an income tax deduction in an amount equal to the taxable income reported by the holders of the restricted shares when the restrictions are released and the shares are issued. Restricted shares are forfeited if officers and employees terminate prior to the lapsing of restrictions. Forfeitures of restricted stock are treated as canceled shares.

The table below provides information for restricted stock awards under the 2013 Plan for the periods indicated:

 

 

 

2019

 

 

2018

 

 

2017

 

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

Per Share

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date

Per Share

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

Per Share

 

Restricted stock at beginning of period

 

 

304,595

 

 

$

21.98

 

 

 

317,783

 

 

$

21.09

 

 

 

343,958

 

 

$

16.60

 

Restricted stock granted

 

 

181,204

 

 

$

22.05

 

 

 

156,771

 

 

$

25.02

 

 

 

127,239

 

 

$

31.06

 

Restricted stock vested

 

 

(99,527

)

 

$

27.56

 

 

 

(106,674

)

 

$

27.11

 

 

 

(139,298

)

 

$

18.73

 

Restricted stock forfeited

 

 

(90,071

)

 

$

13.78

 

 

 

(63,285

)

 

$

15.38

 

 

 

(14,116

)

 

$

24.73

 

Restricted stock at end of period

 

 

296,201

 

 

$

22.91

 

 

 

304,595

 

 

$

21.98

 

 

 

317,783

 

 

$

21.09

 

 

As of December 31, 2019, there was $4.5 million of total unrecognized compensation cost related to nonvested shares granted under the Plan. The cost is expected to be recognized over a weighted-average period of 2.0 years. The total fair value of shares vested during the years ended December 31, 2019, 2018, and 2017 was $2.1 million, $3.0 million, and $4.2 million, respectively.